189 related articles for article (PubMed ID: 12829159)
1. Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed.
Dikomey E; Borgmann K; Peacock J; Jung H
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1194-200. PubMed ID: 12829159
[TBL] [Abstract][Full Text] [Related]
2. The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules.
Burnet NG; Nyman J; Turesson I; Wurm R; Yarnold JR; Peacock JH
Radiother Oncol; 1994 Dec; 33(3):228-38. PubMed ID: 7716263
[TBL] [Abstract][Full Text] [Related]
3. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer.
Hoeller U; Borgmann K; Bonacker M; Kuhlmey A; Bajrovic A; Jung H; Alberti W; Dikomey E
Radiother Oncol; 2003 Nov; 69(2):137-44. PubMed ID: 14643950
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes.
Dunst J; Neubauer S; Becker A; Gebhart E
Strahlenther Onkol; 1998 Oct; 174(10):510-6. PubMed ID: 9810318
[TBL] [Abstract][Full Text] [Related]
5. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients.
Geara FB; Peters LJ; Ang KK; Wike JL; Brock WA
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1173-9. PubMed ID: 8262844
[TBL] [Abstract][Full Text] [Related]
6. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.
Vandevoorde C; Depuydt J; Veldeman L; De Neve W; Sebastià N; Wieme G; Baert A; De Langhe S; Philippé J; Thierens H; Vral A
Int J Radiat Biol; 2016 Dec; 92(12):823-836. PubMed ID: 27586010
[TBL] [Abstract][Full Text] [Related]
7. Normal tissue radiosensitivity in breast cancer patients.
Ramsay J; Birrell G
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):339-44. PubMed ID: 7836087
[TBL] [Abstract][Full Text] [Related]
8. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
9. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy.
Borgmann K; Hoeller U; Nowack S; Bernhard M; Röper B; Brackrock S; Petersen C; Szymczak S; Ziegler A; Feyer P; Alberti W; Dikomey E
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):256-64. PubMed ID: 18406889
[TBL] [Abstract][Full Text] [Related]
10. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?].
Dunst J; Gebhart E; Neubauer S
Strahlenther Onkol; 1995 Oct; 171(10):581-6. PubMed ID: 8571177
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy.
Johansen J; Bentzen SM; Overgaard J; Overgaard M
Radiother Oncol; 1996 Aug; 40(2):101-9. PubMed ID: 8884963
[TBL] [Abstract][Full Text] [Related]
12. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing.
Bentzen SM
Radiother Oncol; 1997 May; 43(2):121-31. PubMed ID: 9192956
[TBL] [Abstract][Full Text] [Related]
13. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.
Bentzen SM; Overgaard M; Overgaard J
Eur J Cancer; 1993; 29A(10):1373-6. PubMed ID: 8398261
[TBL] [Abstract][Full Text] [Related]
14. Correlation between normal tissue complications and in vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for variety of tumors.
Alsbeih G; Malone S; Lochrin C; Girard A; Fertil B; Raaphorst GP
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):143-52. PubMed ID: 10656386
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the radiosensitivity of normal-tissue cells with normal-tissue reactions after radiotherapy.
Slonina D; Klimek M; Szpytma T; Gasinska A
Int J Radiat Biol; 2000 Sep; 76(9):1255-64. PubMed ID: 10993636
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer.
Brock WA; Tucker SL; Geara FB; Turesson I; Wike J; Nyman J; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1371-9. PubMed ID: 7635777
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.
Pinar B; Lara PC; Lloret M; Bordón E; Núñez MI; Villalobos M; Guerrero R; Luna JD; Ruiz de Almodóvar JM
Radiat Res; 2007 Oct; 168(4):415-22. PubMed ID: 17903032
[TBL] [Abstract][Full Text] [Related]
18. Can 8-oxo-dG be used as a predictor for individual radiosensitivity?
Haghdoost S; Svoboda P; Näslund I; Harms-Ringdahl M; Tilikides A; Skog S
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):405-10. PubMed ID: 11380227
[TBL] [Abstract][Full Text] [Related]
19. Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy.
Henríquez-Hernández LA; Carmona-Vigo R; Pinar B; Bordón E; Lloret M; Núñez MI; Rodríguez-Gallego C; Lara PC
Radiat Oncol; 2011 Jun; 6():60. PubMed ID: 21645372
[TBL] [Abstract][Full Text] [Related]
20. Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity.
Burnet NG; Nyman J; Turesson I; Wurm R; Yarnold JR; Peacock JH
Lancet; 1992 Jun; 339(8809):1570-1. PubMed ID: 1351551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
